Ceva Santé Animale

Ceva Santé Animale (Ceva) is a multinational animal health company based in Libourne, France. Established in 1999, Ceva undertakes research, development, production and marketing of pharmaceutical products and vaccines, and also provides complementary services and equipment, for companion animals, poultry, ruminants and swine.

Ceva also supplies; hatchery vaccines, vaccination services and equipment; pheromone-based behavioural products for cats and dogs with additional knowledge in companion animal cardiology, locomotion and dermatology; products for the management of reproduction in ruminants such as antibiotic therapies and vaccines; and a growing range of products for swine, including antibiotic therapies, reproduction management and vaccines.

With revenues of US$1.16 billion (€1.1 billion) for 2017, Ceva is the 6th largest animal health company in the world and the biggest French multinational in the sector based on revenue.

Ceva is based in 45 countries and works in more than 110 countries worldwide. It has 12 research and development centres, 25 production sites and more than 5,500 employees.

In 2010, to mark its 10th anniversary, the company adopted a new mission statement, 'Together, we are building a new reference to create value beyond animal health', abbreviated in the slogan to 'Together, beyond animal health'.

The Chairman and CEO is Marc Prikazsky. Provided by Wikipedia